Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10297 - 10304 of 12011 results
Wyndham Gets Life Preserver in Data Breach Case
June 27, 2014| Blog| Viewpoint
Did The Supreme Court Finally Explain Marathon And Stern? Executive Benefits’ Impact on Bankruptcy Court Jurisdiction
June 27, 2014| Advisory| Viewpoint
Supreme Court Finally Decides Noel Canning and Says President Obama’s Recess Appointments to the NLRB are a No Go.
June 26, 2014| Blog| Viewpoint
Can A Relator Be Held Liable For Using Confidential Company Documents To Support A Qui Tam Case?
June 26, 2014| Blog| Viewpoint
Admirals Bank Partners with SunPower for an Innovative Solar Power Loan Funding Program
June 26, 2014| Blog| Viewpoint
D'oh! OCR Confirms that Medical Records Should Not be Left in the Driveway
June 26, 2014| Blog| Viewpoint
To our US Readers: Your Privacy & Security Matters Blog Public Service for Thursday, June 26
June 26, 2014| Blog| Viewpoint
A Tale of Two Jurisdictions: Human Rights Laws in New York City and Tennessee Head in Opposite Directions
June 25, 2014| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|